《国际妇产科联盟(FIGO)2018癌症报告:子宫内膜癌诊治指南》解读

2019-10-10 中国临床医生杂志.2019.47(10):1155-1158.

子宫内膜癌虽然总体预后较好, 但高级别的子宫内膜癌有复发的倾向, 由于复发性子宫内膜癌预后较差,因此临床上需重视对复发的管理。针对肿瘤生物学制订的治疗方案是平衡治疗功效与不良反应的最佳策略,其基本治疗包括子宫切除术和双侧附件切除术。淋巴结切除术能够识别需要辅助放疗和化疗的淋巴结受累患者( 前哨淋巴结活检的研究正在进行中) 。辅助放疗用于有高危因素的Ⅰ-Ⅲ期患者和淋巴结阴性的I 期患者。在晚期患者中

中文标题:

《国际妇产科联盟(FIGO)2018癌症报告:子宫内膜癌诊治指南》解读

发布机构:

发布日期:

2019-10-10

简要介绍:

子宫内膜癌虽然总体预后较好, 但高级别的子宫内膜癌有复发的倾向, 由于复发性子宫内膜癌预后较差,因此临床上需重视对复发的管理。针对肿瘤生物学制订的治疗方案是平衡治疗功效与不良反应的最佳策略,其基本治疗包括子宫切除术和双侧附件切除术。淋巴结切除术能够识别需要辅助放疗和化疗的淋巴结受累患者( 前哨淋巴结活检的研究正在进行中) 。辅助放疗用于有高危因素的Ⅰ-Ⅲ期患者和淋巴结阴性的I 期患者。在晚期患者中, 完整手术切除加化疗的治疗方案可获得最佳疗效。复发性子宫内膜癌的手术治疗仅建议用于全身状态良好且无病间隔较长的患者。

作者:首都医科大学附属北京妇产医院妇瘤科 金碧霞 孔为民 

拓展指南:子宫内膜癌相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=《国际妇产科联盟(FIGO)2018癌症报告:子宫内膜癌诊治指南》解读)] GetToolGuiderByIdResponse(projectId=1, id=fb0d41c00180e7fb, title=《国际妇产科联盟(FIGO)2018癌症报告:子宫内膜癌诊治指南》解读, enTitle=, guiderFrom=中国临床医生杂志.2019.47(10):1155-1158., authorId=null, author=, summary=子宫内膜癌虽然总体预后较好, 但高级别的子宫内膜癌有复发的倾向, 由于复发性子宫内膜癌预后较差,因此临床上需重视对复发的管理。针对肿瘤生物学制订的治疗方案是平衡治疗功效与不良反应的最佳策略,其基本治疗包括子宫切除术和双侧附件切除术。淋巴结切除术能够识别需要辅助放疗和化疗的淋巴结受累患者( 前哨淋巴结活检的研究正在进行中) 。辅助放疗用于有高危因素的Ⅰ-Ⅲ期患者和淋巴结阴性的I 期患者。在晚期患者中, cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Thu Oct 10 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>子宫内膜癌虽然总体预后较好, 但高级别的子宫内膜癌有复发的倾向, 由于复发性子宫内膜癌预后较差,因此临床上需重视对复发的管理。针对肿瘤生物学制订的治疗方案是平衡治疗功效与不良反应的最佳策略,其基本治疗包括子宫切除术和双侧附件切除术。淋巴结切除术能够识别需要辅助放疗和化疗的淋巴结受累患者( 前哨淋巴结活检的研究正在进行中) 。辅助放疗用于有高危因素的Ⅰ-Ⅲ期患者和淋巴结阴性的I 期患者。在晚期患者中, 完整手术切除加化疗的治疗方案可获得最佳疗效。复发性子宫内膜癌的手术治疗仅建议用于全身状态良好且无病间隔较长的患者。 </P> <P>作者:首都医科大学附属北京妇产医院妇瘤科 金碧霞 孔为民 </P>拓展指南:<strong>与<font color=red>子宫内膜癌</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=bcb2b1c00168106c" title="子宫内膜癌诊治规范(2018年版)" target=_blank>子宫内膜癌诊治规范(2018年版)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=08f6e1c00166080b" title="2018 德国子宫内膜癌跨学科诊断,治疗以及随访指南" target=_blank>2018 德国子宫内膜癌跨学科诊断,治疗以及随访指南</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=1b79e1c00163e149" title="子宫内膜癌诊断与治疗指南(第四版)" target=_blank>子宫内膜癌诊断与治疗指南(第四版)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=de3c21c0016158f1" title="2018 ESUR指南:子宫内膜癌MRI分期(更新)" target=_blank>2018 ESUR指南:子宫内膜癌MRI分期(更新)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=f550d1c0015262de" title="子宫内膜癌筛查和早期诊断专家共识(草案)" target=_blank>子宫内膜癌筛查和早期诊断专家共识(草案)</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E5%AD%90%E5%AE%AB%E5%86%85%E8%86%9C%E7%99%8C" target=_blank>有关子宫内膜癌更多指南</a></ul>, tagList=[TagDto(tagId=850, tagName=子宫内膜癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=10254, appHits=898, showAppHits=70, pcHits=4539, showPcHits=7058, likes=53, shares=23, comments=15, approvalStatus=1, publishedTime=Tue Oct 22 22:03:19 CST 2019, publishedTimeString=2019-10-10, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Oct 22 22:03:19 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 14:13:36 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=《国际妇产科联盟(FIGO)2018癌症报告:子宫内膜癌诊治指南》解读)])
《国际妇产科联盟(FIGO)2018癌症报告:子宫内膜癌诊治指南》解读
下载请点击:
评论区 (13)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1214630, encodeId=610612146305a, content=<a href='/topic/show?id=942b4516096' target=_blank style='color:#2F92EE;'>#子宫内膜癌#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45160, encryptionId=942b4516096, topicName=子宫内膜癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Tue Apr 26 15:49:37 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060348, encodeId=c8b01060348ce, content=早点看到就好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06fa5634764, createdName=ms7000000805881231, createdTime=Thu Oct 14 09:34:24 CST 2021, time=2021-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995881, encodeId=eaa2995881b3, content=不错,挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=287c2571793, createdName=125857b0m79暂无昵称, createdTime=Sat Jul 03 20:37:44 CST 2021, time=2021-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995879, encodeId=b9299958e98f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=287c2571793, createdName=125857b0m79暂无昵称, createdTime=Sat Jul 03 20:37:18 CST 2021, time=2021-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954469, encodeId=7c0f954469f4, content=受益匪浅!好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:04:34 CST 2021, time=2021-04-07, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1214630, encodeId=610612146305a, content=<a href='/topic/show?id=942b4516096' target=_blank style='color:#2F92EE;'>#子宫内膜癌#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45160, encryptionId=942b4516096, topicName=子宫内膜癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Tue Apr 26 15:49:37 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060348, encodeId=c8b01060348ce, content=早点看到就好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06fa5634764, createdName=ms7000000805881231, createdTime=Thu Oct 14 09:34:24 CST 2021, time=2021-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995881, encodeId=eaa2995881b3, content=不错,挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=287c2571793, createdName=125857b0m79暂无昵称, createdTime=Sat Jul 03 20:37:44 CST 2021, time=2021-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995879, encodeId=b9299958e98f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=287c2571793, createdName=125857b0m79暂无昵称, createdTime=Sat Jul 03 20:37:18 CST 2021, time=2021-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954469, encodeId=7c0f954469f4, content=受益匪浅!好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:04:34 CST 2021, time=2021-04-07, status=1, ipAttribution=)]
    2021-10-14 ms7000000805881231

    早点看到就好了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1214630, encodeId=610612146305a, content=<a href='/topic/show?id=942b4516096' target=_blank style='color:#2F92EE;'>#子宫内膜癌#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45160, encryptionId=942b4516096, topicName=子宫内膜癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Tue Apr 26 15:49:37 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060348, encodeId=c8b01060348ce, content=早点看到就好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06fa5634764, createdName=ms7000000805881231, createdTime=Thu Oct 14 09:34:24 CST 2021, time=2021-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995881, encodeId=eaa2995881b3, content=不错,挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=287c2571793, createdName=125857b0m79暂无昵称, createdTime=Sat Jul 03 20:37:44 CST 2021, time=2021-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995879, encodeId=b9299958e98f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=287c2571793, createdName=125857b0m79暂无昵称, createdTime=Sat Jul 03 20:37:18 CST 2021, time=2021-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954469, encodeId=7c0f954469f4, content=受益匪浅!好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:04:34 CST 2021, time=2021-04-07, status=1, ipAttribution=)]
    2021-07-03 125857b0m79暂无昵称

    不错,挺好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1214630, encodeId=610612146305a, content=<a href='/topic/show?id=942b4516096' target=_blank style='color:#2F92EE;'>#子宫内膜癌#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45160, encryptionId=942b4516096, topicName=子宫内膜癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Tue Apr 26 15:49:37 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060348, encodeId=c8b01060348ce, content=早点看到就好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06fa5634764, createdName=ms7000000805881231, createdTime=Thu Oct 14 09:34:24 CST 2021, time=2021-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995881, encodeId=eaa2995881b3, content=不错,挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=287c2571793, createdName=125857b0m79暂无昵称, createdTime=Sat Jul 03 20:37:44 CST 2021, time=2021-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995879, encodeId=b9299958e98f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=287c2571793, createdName=125857b0m79暂无昵称, createdTime=Sat Jul 03 20:37:18 CST 2021, time=2021-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954469, encodeId=7c0f954469f4, content=受益匪浅!好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:04:34 CST 2021, time=2021-04-07, status=1, ipAttribution=)]
    2021-07-03 125857b0m79暂无昵称

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1214630, encodeId=610612146305a, content=<a href='/topic/show?id=942b4516096' target=_blank style='color:#2F92EE;'>#子宫内膜癌#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45160, encryptionId=942b4516096, topicName=子宫内膜癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Tue Apr 26 15:49:37 CST 2022, time=2022-04-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1060348, encodeId=c8b01060348ce, content=早点看到就好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06fa5634764, createdName=ms7000000805881231, createdTime=Thu Oct 14 09:34:24 CST 2021, time=2021-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995881, encodeId=eaa2995881b3, content=不错,挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=287c2571793, createdName=125857b0m79暂无昵称, createdTime=Sat Jul 03 20:37:44 CST 2021, time=2021-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995879, encodeId=b9299958e98f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=287c2571793, createdName=125857b0m79暂无昵称, createdTime=Sat Jul 03 20:37:18 CST 2021, time=2021-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954469, encodeId=7c0f954469f4, content=受益匪浅!好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:04:34 CST 2021, time=2021-04-07, status=1, ipAttribution=)]
    2021-04-07 湘雅科教

    受益匪浅!好文章。

    0